ALX Oncology shareholders elect directors, approve executive compensation and auditor at annual meeting

ALX ONCOLOGY HOLDINGS INC

Vote results: Daniel Curran (100.9M for), Rekha Hemrajani (82.7M for), Chris Takimoto (100.9M for) elected to Class II board.
Say-on-pay advisory vote passed: 84.5M for, 13.5M against, 2.9M abstain.
KPMG LLP ratified as independent auditor for FY2026: 119.3M for, 1.8K against, 9.3K abstain.
All director nominees elected; significant withheld votes for Hemrajani (18.3M) but still elected.

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ALX ONCOLOGY HOLDINGS INC shareholders approved Ratification of the Appointment of Independent Registered Public Accounting Firm at the 2026-06-10 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Proposal 3: Ratification of the Appointment of Independent Registered Public Accounting Firm For Against Abstain 119,293,775 1,797 9,292

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ALX ONCOLOGY HOLDINGS INC shareholders approved Advisory Vote on the Compensation of the Company's Named Executive Officers at the 2026-06-10 meeting.

Proposal: say on pay
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Proposal 2: Advisory Vote on the Compensation of the Company’s Named Executive Officers For Against Abstain Broker Non-Votes 84,540,061 13,497,711 2,953,259 18,313,833

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

ALX ONCOLOGY HOLDINGS INC shareholders approved Election of Two Class II Directors at the 2026-06-10 meeting.

Proposal: director election
Outcome: passed
Meeting: 2026-06-10

Exact text from the filing

Proposal 1: Election of Two Class II Directors Name of Director For Withheld Broker Non-Votes Daniel Curran, M.D. 100,933,233 57,798 18,313,833 Rekha Hemrajani 82,732,430 18,258,601 18,313,833 Chris Takimoto, M.D., Ph.D., F.A.C.P. 100,946,696 44,335 18,313,833

View on SEC.gov

1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →

ALX ONCOLOGY HOLDINGS INC filing history →

Source: SEC EDGAR

accession 0001193125-26-267472

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.